Werewolf Therapeutics, Inc. (HOWL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Luckily, 2025 has given werewolf enthusiasts one of the best stories focusing on the supernatural beasts in recent memory, ...

As of Wednesday, December 17, Werewolf Therapeutics, Inc.’s HOWL share price has surged by 8.80%, which has investors questioning if this is right time to sell.

Horror has a plethora of subgenres, from slashers and zombies, to ghosts and vampires, and many more. An underappreciated subgenre is the werewolf film. Although there were classics like The Wolfman ...

Following the official Marvel Cinematic Universe debut of fan-favorite villain Mephisto, it seems like Marvel Studios is ready to embrace more of the MCU’s supernatural side. That’s why, after more ...

Taylor Lautner, who captured teen hearts as a werewolf in the "Twilight" franchise in the late 2000s, will now hunt the mythical creatures in a new scripted television series starring as himself.

Marvel is about to take a dark turn in Werewolf by Night, the new horror special. We first heard about the project back last year. Then the horror-inspired comic book movie debuted an impressive ...

The Wolf Threat, an immersive gaming experience inspired by the legendary board game, just a short walk from Gare ...